To procure the services to characterize a small molecule pyruvate kinase activator (NCGC-4932) in selected studies to define the solid-state characteristics of the free base of this agent.
Ended Purchase Order Awarded
- Contract number
- 140D0425P0218
- Awardee
-
Davos Chemical Corp. UEI NZL9JLQULS15
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $24,150
Award facts
- Contract value 100% obligated
- $24,150.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Saddle River, NJ 07458, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
The National Center for Advancing Translational Sciences (NCATS) awarded a $24,150 firm fixed-price purchase order to Davos Chemical Corp. to procure analytical characterization services for a small molecule pyruvate kinase activator compound (NCGC-4932). The scope of work involves defining and characterizing the solid-state properties of the free base form of this pharmaceutical agent. This contract represents a targeted procurement supporting NCATS's mission to accelerate the translational process for biomedical research discoveries.
Performance will be conducted at Davos Chemical Corp.'s facility in Saddle River, New Jersey, with an ultimate completion date of September 21, 2026. No set-aside designation was applied to this procurement. The contract was awarded on September 22, 2025, and employs firm fixed-price terms, indicating a defined scope with predetermined costs. As a civilian agency contract with a small award value, this procurement reflects NCATS's support for early-stage characterization work on investigational compounds within its translational research portfolio.
Quick answers
Who was awarded contract 140D0425P0218?
140D0425P0218 was awarded to Davos Chemical Corp. by Interior Business Center (Office of Policy Management and Budget) on September 22, 2025.
How much is contract 140D0425P0218 worth?
The government has obligated $24,150 on 140D0425P0218.
Which agency awarded contract 140D0425P0218?
Interior Business Center (Office of Policy Management and Budget) awarded 140D0425P0218, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 140D0425P0218 competed?
The extent of competition for 140D0425P0218 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award